What is ISO 14971:2019?

ISO 14971:2019 is the international standard that specifies terminology, principles, and a comprehensive process for risk management of medical devices, including software as a medical device and in vitro diagnostic medical devices. The standard establishes a systematic framework for identifying hazards associated with medical devices, estimating and evaluating the associated risks, controlling these risks, and monitoring the effectiveness of the controls throughout the entire device life cycle.

The 2019 edition (third edition) represents a significant evolution from previous versions, with enhanced focus on benefit-risk analysis, expanded requirements for production and post-production activities, and stronger alignment with regulatory requirements in major markets worldwide. The standard requires manufacturers to establish objective criteria for risk acceptability but does not specify acceptable risk levels, recognizing that risk acceptability depends on the specific device context and intended use.

The risk management process described in ISO 14971 applies from initial conception of a medical device through its ultimate decommissioning and disposal, covering all types of risks including those related to biocompatibility, data and systems security, electricity, moving parts, radiation, and usability.

Why is ISO 14971:2019 important?

ISO 14971:2019 is critically important because it provides the internationally recognized framework for managing risks associated with medical devices, directly impacting patient safety and device effectiveness.

The standard's importance extends beyond regulatory compliance. It helps manufacturers make informed decisions about device safety by requiring them to balance residual risks against anticipated clinical benefits. 

Benefits of implementing ISO 14971:2019

Enhanced patient safety and device performance: By systematically identifying and controlling hazards throughout the device life cycle, manufacturers can significantly reduce the likelihood and severity of device-related adverse events, directly protecting patients and users.

Structured decision-making framework: The standard provides a clear, systematic approach for making risk-related decisions, helping manufacturers balance safety considerations with device functionality and intended benefits.

Integration with quality management systems: Risk management can be seamlessly integrated into quality management systems based on ISO 13485, creating operational efficiencies and ensuring consistency across organizational processes.

Proactive hazard identification and control: The standard encourages early identification of potential hazards during design and development, when mitigation strategies are most cost-effective and impactful, reducing costly redesigns and recalls.
Improved post-market surveillance: Requirements for production and post-production information gathering help manufacturers identify emerging risks and safety concerns early, enabling rapid response to protect patients.